Table 3 Text mining score and overall association score of neurological diseases associated with CHI3L1, APP, and DRD2 on the Open Targets Platform.
From: Significance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer
CHI3L1-neurological diseases | APP-neurological diseases | DRD2-neurological diseases | |||||||
|---|---|---|---|---|---|---|---|---|---|
Name | Text Mining | Overall Association Score | Name | Text Mining | Overall Association Score | Name | Text Mining | Overall Association Score | |
Alzheimer disease | 0.919 | 0.113 | Alzheimer disease | 0.995 | 0.824 | Schizophrenia | 0.942 | 0.732 | |
Obstructive sleep apnea | 0.793 | 0.096 | Neuroblastoma | 0.931 | 0.113 | Parkinson disease | 0.826 | 0.636 | |
Amyotrophic lateral sclerosis | 0.667 | 0.081 | Dravet syndrome | 0.898 | 0.109 | Alcohol dependence | 0.779 | 0.611 | |
Pick disease | 0.663 | 0.081 | Parkinson disease | 0.774 | 0.094 | Psychosis | 0.757 | 0.624 | |
Age-related macular degeneration | 0.625 | 0.076 | Experimental autoimmune encephalomyelitis | 0.694 | 0.084 | Alzheimer disease | 0.668 | 0.428 | |
Carotid atherosclerosis | 0.525 | 0.064 | Schizophrenia | 0.693 | 0.092 | Insomnia | 0.648 | 0.097 | |
Glioblastoma multiforme | 0.493 | 0.069 | Autism | 0.690 | 0.083 | Autism | 0.631 | 0.624 | |
Temporal arteritis | 0.464 | 0.056 | Cerebral amyloid angiopathy | 0.689 | 0.361 | Prolactin-producing pituitary gland adenoma | 0.613 | 0.083 | |
Astrocytoma | 0.438 | 0.055 | Brain ischemia | 0.607 | 0.073 | Glioblastoma | 0.608 | 0.073 | |
Glioblastoma | 0.435 | 0.053 | Glioblastoma | 0.513 | 0.062 | Attention deficit hyperactivity disorder | 0.572 | 0.658 | |
Sporadic amyotrophic lateral sclerosis | 0.425 | 0.052 | Familial Alzheimer disease | 0.455 | 0.055 | Experimental autoimmune encephalomyelitis | 0.488 | 0.059 | |
Lewy body dementia | 0.365 | 0.044 | Huntington disease | 0.419 | 0.051 | Lewy body dementia | 0.425 | 0.051 | |
Polymyositis | 0.312 | 0.038 | Nervous system disease | 0.331 | 0.040 | Conduct disorder | 0.419 | 0.556 | |
Cerebral amyloid angiopathy | 0.305 | 0.037 | Stroke | 0.317 | 0.392 | Huntington disease | 0.417 | 0.393 | |
Dermatomyositis | 0.277 | 0.034 | Age-related macular degeneration | 0.291 | 0.035 | Post-traumatic stress disorder | 0.384 | 0.585 | |
Glioma | 0.238 | 0.029 | Amyotrophic lateral sclerosis | 0.289 | 0.050 | Catalepsy | 0.377 | 0.045 | |
Schizophrenia | 0.237 | 0.377 | Fragile X syndrome | 0.268 | 0.032 | Dyslexia | 0.364 | 0.044 | |
Multiple sclerosis | 0.221 | 0.027 | Neurodegenerative disease | 0.264 | 0.032 | Cocaine dependence | 0.330 | 0.469 | |
Cognitive disorder | 0.218 | 0.027 | Tauopathy | 0.228 | 0.027 | Fabry disease | 0.305 | 0.0371 | |
Relapsing-remitting multiple sclerosis | 0.213 | 0.026 | Brain injury | 0.226 | 0.027 | Migraine disorder | 0.282 | 0.590 | |